Literature DB >> 17385034

Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients.

Motoyasu Kusano1, Yasuyuki Shimoyama, Osamu Kawamura, Masaki Maeda, Shikou Kuribayashi, Atsuto Nagoshi, Hiroaki Zai, Fumitaka Moki, Tsutomu Horikoshi, Munetoshi Toki, Sayaka Sugimoto, Masatomo Mori.   

Abstract

It has been reported that proton pump inhibitors are more effective than H2 receptor antagonists in patients with functional dyspepsia. Dyspeptic symptoms that respond to proton pump inhibitors are classified as acid-related dyspepsia. A new questionnaire for assessing gastroesophageal reflux disease (GERD), the Frequency Scale for Symptoms of GERD, covers the 12 most common symptoms of GERD patients. A quantitative assessment of the changes of reflux symptoms and acid-related dyspepsia was made in GERD patients receiving proton pump inhibitor therapy. Sixty-eight GERD patients receiving proton pump inhibitor therapy completed the questionnaire before and after treatment for 8 weeks. There is a significant positive correlation between reflux symptoms and acid-related dyspepsia before and after therapy (r = 0.569 and r = 0.569; both P's < 0.001) and acid-related dyspepsia in patients with both nonerosive and erosive GERD. We conclude that GERD patients suffer not only from reflux symptoms, but also from acid-related dyspepsia, and proton pump inhibitors improve both types of symptoms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17385034     DOI: 10.1007/s10620-006-9674-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  17 in total

1.  Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease.

Authors:  G J Maddern; G G Jamieson; J C Myers; P J Collins
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

2.  The endoscopic assessment of esophagitis: a progress report on observer agreement.

Authors:  D Armstrong; J R Bennett; A L Blum; J Dent; F T De Dombal; J P Galmiche; L Lundell; M Margulies; J E Richter; S J Spechler; G N Tytgat; L Wallin
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

3.  Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor.

Authors:  Kayoko Oda; Ryuichi Iwakiri; Megumi Hara; Kazuyo Watanabe; Akiko Danjo; Ryo Shimoda; Atsushi Kikkawa; Akifumi Ootani; Hiroyuki Sakata; Seiji Tsunada; Kazuma Fujimoto
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

4.  Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice.

Authors:  R H Jones; G Baxter
Journal:  Aliment Pharmacol Ther       Date:  1997-06       Impact factor: 8.171

5.  Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia.

Authors:  J Tack; P Caenepeel; B Fischler; H Piessevaux; J Janssens
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

6.  Development and evaluation of FSSG: frequency scale for the symptoms of GERD.

Authors:  Motoyasu Kusano; Yasuyuki Shimoyama; Sayaka Sugimoto; Osamu Kawamura; Masaki Maeda; Keiko Minashi; Shiko Kuribayashi; Tatsuya Higuchi; Hiroaki Zai; Kyoko Ino; Tsutomu Horikoshi; Tadashi Sugiyama; Munetoshi Toki; Tsuneo Ohwada; Masatomo Mori
Journal:  J Gastroenterol       Date:  2004-09       Impact factor: 7.527

Review 7.  Review article: gastric emptying in functional gastrointestinal disorders.

Authors:  E M M Quigley
Journal:  Aliment Pharmacol Ther       Date:  2004-11       Impact factor: 8.171

Review 8.  Today's therapy of functional gastrointestinal disorders--does it help?

Authors:  A Berstad
Journal:  Eur J Surg Suppl       Date:  1998

9.  A placebo-controlled trial of itopride in functional dyspepsia.

Authors:  Gerald Holtmann; Nicholas J Talley; Tobias Liebregts; Birgit Adam; Christopher Parow
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

10.  A comparison of five maintenance therapies for reflux esophagitis.

Authors:  S Vigneri; R Termini; G Leandro; S Badalamenti; M Pantalena; V Savarino; F Di Mario; G Battaglia; G S Mela; A Pilotto
Journal:  N Engl J Med       Date:  1995-10-26       Impact factor: 91.245

View more
  24 in total

1.  Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia.

Authors:  Yoshikazu Kinoshita; Hiroto Miwa; Katsuyuki Sanada; Koji Miyata; Ken Haruma
Journal:  J Gastroenterol       Date:  2013-05-08       Impact factor: 7.527

2.  Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.

Authors:  Kimio Isshi; Nobuyuki Matsuhashi; Takashi Joh; Kazuhide Higuchi; Katsuhiko Iwakiri; Takeshi Kamiya; Noriaki Manabe; Maiko Ogawa; Seiji Arihiro; Ken Haruma; Koji Nakada
Journal:  J Gastroenterol       Date:  2019-01-23       Impact factor: 7.527

3.  Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.

Authors:  Takahisa Furuta; Tomohiko Shimatani; Mitsushige Sugimoto; Shunji Ishihara; Yasuhiro Fujiwara; Motoyasu Kusano; Tomoyuki Koike; Michio Hongo; Tsutomu Chiba; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2011-08-24       Impact factor: 7.527

4.  Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.

Authors:  Toshihisa Takeuchi; Hitoshi Hongo; Tsuguhiro Kimura; Yuichi Kojima; Satoshi Harada; Kazuhiro Ota; Nozomi Takeuchi; Takao Noguchi; Takuya Inoue; Mitsuyuki Murano; Kazuhide Higuchi
Journal:  J Gastroenterol       Date:  2019-04-29       Impact factor: 7.527

5.  Proton pump inhibitor after endoscopic resection for esophageal squamous cell cancer: multicenter prospective randomized controlled trial.

Authors:  N Kakushima; K Hori; H Ono; T Horimatsu; N Uedo; K Ohata; H Doyama; K Kaneko; I Oda; T Hikichi; Y Kawahara; K Niimi; Y Takaki; M Mizuno; S Yazumi; A Hosokawa; A Imagawa; M Niimi; K Yoshimura; M Muto
Journal:  J Gastroenterol       Date:  2015-05-05       Impact factor: 7.527

6.  Assessment of gastroesophageal reflux disease by serodiagnosis of Helicobacter pylori-related chronic gastritis stage.

Authors:  Shotaro Enomoto; Masashi Oka; Hiroshi Ohata; Chizu Mukoubayashi; Mika Watanabe; Kosaku Moribata; Yosuke Muraki; Naoki Shingaki; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Kimihiko Yanaoka; Hideyuki Tamai; Mitsuhiro Fujishiro; Osamu Mohara; Masao Ichinose
Journal:  World J Gastrointest Endosc       Date:  2011-04-16

7.  Characteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients.

Authors:  Kenichiro Nakagawa; Tomoyuki Koike; Katsunori Iijima; Masahiro Saito; Hiroki Kikuchi; Waku Hatta; Nobuyuki Ara; Kaname Uno; Naoki Asano; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

Review 8.  Patient satisfaction with medication for gastroesophageal reflux disease: a systematic review.

Authors:  Sander Jo van Zanten; Catherine Henderson; Nesta Hughes
Journal:  Can J Gastroenterol       Date:  2012-04       Impact factor: 3.522

9.  Combination of angiotensin II receptor blockers promotes proton pump inhibitor-based healing of reflux esophagitis.

Authors:  Hiroto Miwa; Michio Hongo; Motoyasu Kusano
Journal:  J Gastroenterol       Date:  2011-11-01       Impact factor: 7.527

10.  Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan.

Authors:  Kazunari Tominaga; Ryuichi Iwakiri; Kazuma Fujimoto; Yasuhiro Fujiwara; Mio Tanaka; Yasuyuki Shimoyama; Eiji Umegaki; Kazuhide Higuchi; Motoyasu Kusano; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2011-11-15       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.